Search Within

Tooba Imtiaz

Formats
  1. Meeting Abstract (7)
Groups
  1. Department of Medicine (7)
  2. Gastrointestinal Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Department of Pathology and Laboratory Medicine (6)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. David Ilson (7)
  2. Yelena Janjigian (7)
  3. Efsevia Vakiani (6)
  4. David Kelsen (5)
  5. Geoffrey Ku (5)
  6. Michael Berger (5)

More People

Years
  1. 2015 (4)
  2. 2014 (3)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genomic profiling of esophagogastric (EG) tumors in clinical practice
    Meeting Abstract

    Riches, J. C.; Schultz, N.; Ku, G. Y.; Imtiaz, T.; Kelsen, D. P.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab
    Meeting Abstract

    Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Vakiani, E.; Imtiaz, T.; Huang, X.; Ilson, D. H.; Rizk, N. P.; Coit, D. G.; Strong, V. E.; de Stanchina, E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Imtiaz, T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save